Eddie Best on Expectations for Anthropic’s IPO
THE SO WHAT
Anthropic potentially pricing up from $70 to $83 per share shows public markets are still willing to pay for frontier AI exposure despite governance and capex questions. If you’re an enterprise buyer, expect vendor valuations to keep subsidizing aggressive roadmap promises—and negotiate long-term commitments while that window is open.
READ THE SOURCE
MORE FROM THE WIRE
Startups & VentureAnthropic IPO Hands SK Hynix Tycoon’s Firm $3 Billion Windfall
A multibillion-dollar gain for SK’s empire from Anthropic’s IPO shows how upstream hardware and telco players are using equity to participate in AI economics, not just selling bits and bandwidth. If you’re a large infra provider without structured upside in your customers’ AI growth, your board will start asking why.
Startups & VentureThe Biggest Winners in Anthropic’s Landmark Public Offering
Anthropic’s IPO is crystallizing multi‑billion‑dollar returns for its backers—LPs now have proof that frontier labs can exit, not just raise. Expect more capital to chase foundation model exposure and higher expectations on your path to liquidity if you’re anywhere near the model layer.
Startups & VentureChina AI Biotech Firm Raises $200 Million in Oman-Backed Round
MegaRobo’s nearly $200M raise with Oman’s sovereign fund backing shows Gulf capital is now comfortable underwriting AI‑plus‑robotics drug discovery in China. Biotech operators should assume global competition for lab automation talent and hardware will tighten over the next 12–24 months.
Startups & VentureAnthropic Raises $3 Billion in Japan Tranche of US Mega IPO
A $3B Japan tranche at the low end of the range still shows there’s deep non-US demand for AI equity exposure — but pricing discipline is back. For operators, this is a signal that public markets will fund scaled AI plays, yet expect clearer paths to vertical revenue than the 2021-era story stock.